A new oral drug for relapsing forms of multiple sclerosis appears to reduce relapse rates and disability progression, according to the results of a so-called phase 3 trial. The experimental drug, teriflunomide, is one of the few oral drugs that treat this type of MS and may, if approved, be a good choice for many MS patients, researchers said…Dr. Moses Rodriguez, professor of neurology and immunology at the Mayo Clinic in Rochester, Minn., said teriflunomide appears to be relatively safe in contrast to other drugs for MS. "I am impressed that there were not many serious infections, which makes this an attractive drug for MS patients," Rodriguez said.
HealthDay, Steven Reinberg, 10/6/11
Additional coverage: US News & World Report